Navigation Links
KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results
Date:8/11/2008

rter reflected the following:

-- $4.6 million related to one-time launch related marketing expenses for the initial launch and supply of the 25 mg and 50 mg strength of metoprolol succinate extended-release tablets;

-- $1.5 million increase in expense associated with foreign currency transaction losses on investments denominated in the Indian Rupee;

-- $3.8 million of launch-related marketing and promotion expenses related to Evamist(TM);

-- $2.6 million increase in personnel costs due to increases in management, sales and other personnel, of which $1.4 million was related to the expansion for our branded sales force initiated in the third quarter of fiscal 2008;

-- $1.8 million increase in branded marketing and promotions expense on our existing brands;

-- $1.5 million increase in costs associated with redistribution fees paid to certain major wholesalers and chains for single point shipping services; and

-- $1.2 million increase in expenses for consulting and other professional services.

Net Income

Net income for the quarter increased $6.3 million, or 102.2%, to $12.5 million, or $0.23 per diluted Class A common share, compared to $6.2 million or $0.12 per diluted Class A common share for the first quarter of fiscal 2008.

Financial Condition

The Company's liquidity remains strong with cash and marketable securities of $135.1 million at the end of the quarter and $15.7 million of cash flow generated from operations in the first quarter. The Company also holds $79.9 million in auction-rate securities, which are currently illiquid and classified as long-term investments. The Company is encouraged by proposed and announced settlements reached with regulatory authorities by several banks that show signs that the liquidity problem with these types of securities is finally being addressed. Capital expenditures increased to $5.3 million in the first quarter of fiscal 2009 compared with $2.1 milli
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Banzel proved effective against Lennox-Gastaut syn...s) -- A new drug called Banzel (rufinamide) has be...ere form of epilepsy called Lennox-Gastaut syndrom... Friday. , The approval was based on results of...s ages 4 to 30. Compared to patients who took a pl...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
(Date:11/21/2008)...popular drugs do not cause genetic damage that can...althDay News) -- Two popular medications for treat...) do not cause genetic damage linked to an increas..., The study, done by researchers at Duke Univers...Health, counters a previous one that reported biom...
(Date:11/21/2008)...N.Y., Nov. 21 A prestigious group ...ders will gather in Williamsburg, VA on March 27-2...al, clinical information on cutting-edge therapeut...ovative research advances that impact patient care...gistration information is available at www.biocon...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2
... Daniel Musher, MD, studied the records of all 170... at a Texas Veterans Affairs medical center from ... with pneumonia may be at serious risk of new or w...at 19.4 percent of them had a heart attack or othe...
... geneticists say that they have developed a faster... mutants in large, non-gene stretches of DNA. The...ause diseases can result not only from mutant gene...DNA that controls genes. "Diseases are known to o...
... disease that can cause blindness and affects mill...ely get past the blood-brain barrier making it an...Sudipta Seal, an engineering professor with appoin...ssing and Analysis Center and the Nanoscience Tech...
...sts that playing with candy cigarettes may favorab... future cigarette smokers . The study, reported ...at in a nationally representative sample of 25,887... never consumed candy cigarettes were 12% in curre...
Other Medicine News:Health News:Pneumonia Patients Develop Heart Risks 2Health News:Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA 2Health News:Nanoparticle in the Treatment of Glaucoma 2Health News:The Danger in Candy Cigarettes 2
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:...and drug development Company,and Sosei Group Cor...ding,international biopharmaceutical company, tod...ther pivotal pre-clinical efficacy data for NSL-04... therapy for neuropathic pain and has,successfull...
(Date:11/18/2008)...8 Arlington Medical Resources (AMR...the pharmaceutical and diagnostic,imaging industr...Privigen was,sold in the U.S. during the third qu...travenous immune globulin (IVIG) and was launched ...reated from the blood plasma of thousands,of dono...
(Date:11/18/2008)...ation,s 2008 Faces of Influenza survey underscores...st influenza; Mother and Gold Medalist Kristi Yama.... 18 While 78 percent of mothers i...d potentially life-threatening disease that can st...lies will get vaccinated this season, according to...
(Date:11/13/2008)...Nov. 13 Hologic, Inc.,(N...and supplier of premium,diagnostics, medical imagi...ing the healthcare needs of women, today announced... clinical trial. The Cervista HPV high-risk,test i...d is expected to be,launched in the European Union...
Breaking Medicine Technology:Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 20317 1The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 20317 2The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 20317 3Techno Savvy Public Awareness Campaign Enables Families to Send a Powerful Message About Childrens Mental Health 20313 1Techno Savvy Public Awareness Campaign Enables Families to Send a Powerful Message About Childrens Mental Health 20313 2Acuity Workflow Solutions 28TM 29 Enhances Medical Case Management Process 3A 20309 1Acuity Workflow Solutions 28TM 29 Enhances Medical Case Management Process 3A 20309 2TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO 3A Intravenous Infusions of Rexin G Followed by Reximmune C Induce Tumor Necrosis and Recrui 2197 1TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO 3A Intravenous Infusions of Rexin G Followed by Reximmune C Induce Tumor Necrosis and Recrui 2197 2TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO 3A Intravenous Infusions of Rexin G Followed by Reximmune C Induce Tumor Necrosis and Recrui 2197 3
...to hospitalization and drug withdrawal, CHICAGO, M...ds,of migraine patients and physicians commissione...d by Harris Interactive shows that,20 percent of m...addictive medications that contain barbiturates or...od and Drug Administration for the,relief of migra...
...broad range of clinical data on leading,drug-eluti...RNewswire-FirstCall/ -- Boston,Scientific Corporat...major events and press announcements at the annual...h will runs from May 22,to 25 in Barcelona, Spain.... our clinical,trials and registries, adding to the...
Other Medicine Technology:Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 2Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 3Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 4Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 5Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 6Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5
... microscope. It has the ability to take a non-cont...ly. It also has the ability to measure the corneal...ells is displayed on the 9" monitor, which is supp... same as the model CC-5000 with a few very importa...
...) Contact Lenses are rigid gas permeable contact l...porarily corrects nearsightedness (myopia). The pa...m in the morning. During the day, nearsightedness ... Euclid Systems Orthokeratology (oprifocon A) Cont...
...ronic angina or end stage cardiovascular disease? ... patients nationwide, External Counterpulsation (E...s allowed many to perform normal activities of dai... provider of cardiac diagnostic services, has assi...
...ht, ,Konan realized an ideal coaxial illuminat... observation. This illumination should be ideal fo...,Konan offers what no other conventional compact...nd a clear image at every possible magnification.,...
Medicine Products: